Eyecarrot Announces Change of Name to Binovi Technologies Corp and the Postponement of Annual Financial Statements

TORONTO, ON and NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Eyecarrot Innovations Corp., (Eyecarrot) (TSX-V:EYC)(OTCQB:EYCCF)(2EYA:GR) a leader is neuro-vision performance technology, announces that its Board of Directors has approved a name change from Eyecarrot Innovations Corp. to Binovi Technologies Corp. In connection with the name change, the Company’s trading symbol on the TSX Venture Exchange (“TSXV”) will be changed to ‘VISN’. It is expected that the name change will be effected on or about June 30, 2020 and the Company’s common shares will begin trading under the new name and symbol upon market open on Thursday July 2, 2020, subject to final approval by TSXV. The CUSIP number assigned to the Company’s shares following the name change is 09076N109 (ISIN: CA09076N1096). No action is required to be taken by shareholders with respect to the name change. Outstanding share and warrant certificates are not affected by the name change and do not need to be exchanged.

Postponement of Annual Financial Statements

The Company announces the postponement of filing its annual financial statements and management’s discussion and analysis (collectively the “Annual Statements”) for the year ended February 29, 2020 due to logistics and delays caused by the COVID-19 pandemic.

The Company is relying on exemptive relief granted by Canadian securities regulatory authorities that allows it to delay the filing of its Annual Statements required by sections 4.2 and 5.12(2) of National Instrument 51-102 due to be filed by June 29, 2020. In response to the coronavirus disease pandemic, securities regulatory authorities in Canada have granted a blanket exemption allowing issuers an additional 45 days to complete their regulatory filings.

Eyecarrot anticipates that its Annual Statements will be available for filing at its earliest opportunity, which is expected to occur on or before August 12, 2020. Until such time as the Annual Statements are filed, the Company’s management and insiders are subject to a trading blackout that reflects the principals contained in section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

Other than as previously disclosed by the Company in news releases, there have been no material business developments since the date of the last interim financial statements filed on January 30, 2020, copies of which are available under the Company’s profile on SEDAR at www.sedar.com. The Company will be providing an update news release on the status of filing its February 29, 2020 audited financial statements and its May 30, 2020 first quarter unaudited financial statements by July 29, 2020.

AGORACOM Agreement

The Company announces that further to its news release dated April 28, 2020, it will make its first issuance of shares under its online marketing and awareness program with Agora Internet Relations Corp. (“AGORACOM”). Pursuant to this first tranche, the Company will issue 52,154 common shares of the Company at a deemed price of $0.26. AGORACOM’s program includes a “CEO Verified” Discussion Forum. The forum serves as the Company’s primary social media platform to interact with both shareholders and the broader investment community in a fully moderated environment.

The Eyecarrot HUB can be found at https://agoracom.com/ir/EyecarrotInnovations.

For additional information on the Company, please visit https://www.eyecarrot.com/investors/.

About Binovi by Eyecarrot

Eyecarrot Innovations Corp. is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.

Terry Booth
Executive Chairman

Adam Cegielski
Founder | CEO
Investor Relations
Email: invest@eyecarrot.com
Toll-free: 1 (844) 866-6162
https://www.eyecarrot.com/investors/

Forward looking information

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com. The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Eyecarrot Innovations Corp.

View source version on accesswire.com:
https://www.accesswire.com/595608/Eyecarrot-Announces-Change-of-Name-to-Binovi-Technologies-Corp-and-the-Postponement-of-Annual-Financial-Statements

Staff

Recent Posts

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

32 minutes ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

32 minutes ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

2 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago